ECLIPSYS
Live / Registered — Registered (as of 03 Oct 2023)
What this means for you
Registered since 03 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97409708
- Registration number
- 7179544
- Mark type
- Stylized text
- Filed
- 13 May 2022
- Published for opposition
- 18 Jul 2023
- Registered
- 03 Oct 2023
- Attorney of record
- Rob LeBlanc
Goods and services
- Class 001 — Chemicals: Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or research use; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
- Class 005 — Pharmaceuticals: Pharmaceuticals, medicinal and veterinary preparations for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; none of the aforesaid goods being for the treatment and care of wounds and none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific analysis, testing, engineering, development, research, and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medicinal preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological and chemical testing; research and development in the pharmaceutical, chemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
Owner
- Amphista Therapeutics Limited, Zurich, GB
- Amphista Therapeutics Limited, Cambridge, GB
- Amphista Therapeutics Limited, Cambridge, GB
Prosecution history
- 22 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jul 2023 — PUBLISHED FOR OPPOSITION
- 28 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED